All Financial Statements for 2007 Now Available in US GAAP
TORONTO, Jan. 29 /CNW/ - MDS Inc. (TSX: MDS; NYSE: MDZ), a leading
provider of products and services to the global life sciences markets, today
announced that it has issued its annual filings for the first time under US
GAAP. These filings include the Annual Report, Annual Information Form,
Management Proxy Circular, 40-F, and the Canadian Supplement to the annual
To assist investors with understanding the impact of the conversion from
Canadian to US GAAP, both an "MDS US GAAP Primer", which provides an overview
of the relevant differences between US and Canadian GAAP affecting MDS, and
reconciliation tables for MDS and its business units are being made available
on the MDS website.
MDS also published its interactive annual report today available at
About MDS Inc.
MDS Inc. is a global life sciences company that provides market-leading
products and services that our customers need for the development of drugs and
the diagnosis and treatment of disease. We are a leading global provider of
pharmaceutical contract research, medical isotopes for molecular imaging,
radiotherapeutics, and analytical instruments. MDS has more than 5,500 highly
skilled people in 29 countries. Find out more at www.mdsinc.com or by calling
1-888-MDS-7222, 24 hours a day.
For further information:
For further information: Sharon Mathers, Senior Vice-President, Investor
Relations and External Communications, MDS Inc., (416) 675-6777 X 34721,